12
Targeted Sequencing Panels on GIAB Benchmark Genomes Megan Cleveland, Ph.D. Applied Genetics Group - NIST Genome in a Bottle Consortium Workshop September 15, 2016

GIAB Sep2016 Lightning megan cleveland targeted seq

Embed Size (px)

Citation preview

Page 1: GIAB Sep2016 Lightning megan cleveland targeted seq

Targeted Sequencing Panels on GIAB

Benchmark GenomesMegan Cleveland, Ph.D.

Applied Genetics Group - NIST

Genome in a Bottle Consortium WorkshopSeptember 15, 2016

Page 2: GIAB Sep2016 Lightning megan cleveland targeted seq

Purpose - Goals• To perform targeted sequencing of GiaB reference materials (and

candidates)• Using commercial assays

• Further characterization of GiaB with assays of interest (clinical relevance) • Compare to high confidence regions• Identify/mitigate any discordant base calls• Potentially add new high confidence sequence information to the materials

Working in coordination with Justin and Marc

Page 3: GIAB Sep2016 Lightning megan cleveland targeted seq

Samples for Targeted Sequencing

NA12878

Ashkenazi Trio RM 8392

Asian Trio

GM24143GM24149

GM24385NIST RM 8391

GM24695GM24694

GM24631NIST RM 8393

Caucasian FemaleNIST RM 8398

7 Individuals3 replicates

Page 4: GIAB Sep2016 Lightning megan cleveland targeted seq

Selection Targeted Sequencing Panels

Ion AmpliSeq™ Pharmacogenomics PanelIon AmpliSeq™ Cancer Hotspot Panel v2Ion AmpliSeq™ Comprehensive Cancer PanelIon AmpliSeq™ Inherited Disease PanelIon AmpliSeq™ Exome Panel HID-Ion AmpliSeq™ Identity PanelHID-Ion AmpliSeq™ Ancestry Panel

TruSight OneTruSight HLATruSight RNA Pan-CancerTruSight MyeloidTruSight CancerTruSight Tumor 15TruSight CardioTruSight Inherited Disease

A starting point – input is welcome!

Page 5: GIAB Sep2016 Lightning megan cleveland targeted seq

Overlap between TruSight and AmpliSeq IDPs

TruSight Inherited Disease Panel550 genes

AmpliSeq Inherited Disease Panel328 genes

454 96 232

Regions of interest are captured by hybridization to

biotinylated probes and isolated by magnetic pulldown.

Regions of interest are amplified using >10,000

primer pairs

Page 6: GIAB Sep2016 Lightning megan cleveland targeted seq

Comparing the Inherited Disease Panels to the GIAB truth set

Page 7: GIAB Sep2016 Lightning megan cleveland targeted seq

Data Analysis

SequenceReplicate 1 IDP VCF

Generate VCF with corresponding commercial Software

GIABVCF

IDP VCF

Compare the VCF files(ideal would be 100% overlap)

SequenceReplicate 2 IDP VCF

Generate VCF with corresponding commercial Software

GIABVCF

IDP VCF

Compare the VCF files(ideal would be 100% overlap)

SequenceReplicate 3 IDP VCF

Generate VCF with corresponding commercial Software

GIABVCF

IDP VCF

Compare the VCF files(ideal would be 100% overlap)

Page 8: GIAB Sep2016 Lightning megan cleveland targeted seq

VCF from AmpliSeq or TruSight IDP

GIAB VCF

Intersection of GIAB and IDP bed files

Page 9: GIAB Sep2016 Lightning megan cleveland targeted seq

GIABTruth

bed file

Inherited DiseasePanelbed file

New BedFile

Intersection of the Two Bed Files

~90% of each IDP covered in GIAB bed file

Page 10: GIAB Sep2016 Lightning megan cleveland targeted seq

Examine Discordant Results in IGV• Vcfeval + Hap.py reports false negatives and false positives, with

respect to the GIAB VCF• The alignments in those locations are examined in IGV to determine

why the result is discordant

Source: broadinstitute.org

Page 11: GIAB Sep2016 Lightning megan cleveland targeted seq

We welcome input regarding:• Additional panels• Data analysis • Other

[email protected]

Page 12: GIAB Sep2016 Lightning megan cleveland targeted seq

Acknowledgements• Applied Genetics Group

• Pete Vallone• Kevin Kiesler• Lisa Borsuk

• Genome Scale Measurements Group• Justin Zook• Marc Salit• Jennifer McDaniel• David Catoe• Lindsay Vang

Please email me with any questions or comments

[email protected]